Late hepatitis C virus diagnosis among patients with newly diagnosed hepatocellular carcinoma: a case–control study
Abstract Background New direct-acting antiviral therapies have revolutionized hepatitis C virus (HCV) infection therapy. Nonetheless, once liver cirrhosis is established, the risk of hepatocellular carcinoma (HCC) still exists despite virus eradication. Late HCV diagnosis hinders timely access to HC...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2022-09-01
|
| シリーズ: | BMC Gastroenterology |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s12876-022-02504-6 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
